Moxifloxacin Tablets: Why This Antibiotic Is Reserved for Specific Situations
Moxifloxacin is a fluoroquinolone antibiotic that works well against a range of respiratory and other infections. It is also a medicine that European and UK regulators have deliberately pushed down the prescribing hierarchy. The reason is not that it fails to treat infections, but that its risk profile—liver reactions, heart rhythm effects, tendon damage—makes it a poor first choice for most people. For adults in Denmark and the UK, understanding moxifloxacin means understanding both what it can do and why a doctor might reach for something else first. What Moxifloxacin Is Approved to Treat Moxifloxacin tablets are authorised for several bacterial infections, including acute bacterial sinusitis, acute exacerbations of chronic bronchitis, community-acquired pneumonia, and complicated skin and intra-abdominal infections . The standard adult dose is 400 mg once daily, with treatment durations varying by indication—five days for bronchitis, seven to fourteen days for pneumonia . The ...